Table 2.
Failure-free Survival for Infants by Patient Characteristics
| Characteristic | Total | % | 5-yr FFS (%) | p-value |
|---|---|---|---|---|
| Age | ||||
| < 3 months | 13 | 17 | 59 | 0.86 |
| ≥ 3 months | 63 | 83 | 56 | |
| Site | ||||
| Favorable | 29 | 38 | 52 | 0.43 |
| Unfavorable | 43 | 57 | 61 | |
| Histology | ||||
| Embryonal | 43 | 57 | 64 | 0.04 |
| Alveolar | 16 | 21 | 22 | |
| UDS/Other | 17 | 22 | 69 | |
| Tumor Size | ||||
| ≤ 5cm | 45 | 59 | 59 | 0.86 |
| > 5cm | 31 | 41 | 54 | |
| T-Stage | ||||
| T-1 | 45 | 59 | 59 | 0.48 |
| T-2 | 31 | 41 | 53 | |
| Nodes | ||||
| N0 | 63 | 84 | 56 | 0.97 |
| N1 | 9 | 12 | 65 | |
Favorable Site: non-parameningeal Head & Neck, Orbit, GU non-Bladder/Prostate
Unfavorable Site: Parameningeal, Extremity, Trunk/Abdomen, Bladder/Prostate
UDS, undifferentiated sarcoma